The Biden administration is increasing funding to enhance the nation's pandemic preparedness before the new administration takes over.
Nearly $306 million will be allocated for hospital readiness and research on therapeutics, diagnostics, and vaccines against H5N1, a dangerous bird flu strain.
Health officials are monitoring the H5N1 strain closely, although the risk to humans currently remains low.
Funds will also support efforts to track and test individuals who may have been exposed to infected animals, focusing on high-risk workers.
So far, more than $1.8 billion has been spent on bird flu initiatives, with new funds to be distributed in the next two weeks.
For further details, you can read the original article here.